éå»1ã¶æéã«ACADIA Pharmaceuticals Incã«å¯ŸããŠè©äŸ¡ãåºããã¢ããªã¹ã21åã«åºã¥ãããŒã¿ã
仿ãACADã¯10ä»¶ã®ãè²·ããã4ä»¶ã®ãäžç«ïŒããŒã«ãïŒãã1ä»¶ã®ã売ããè©äŸ¡ãç²åŸããŸãããçŽè¿1ã¶æã«ãããACADã®ã¢ããªã¹ãå¹³åç®æšæ ªäŸ¡ã¯32.056ã§ãã
ã¢ããªã¹ãäºæ³ã«ãããšãFY2026Q2ã«çºè¡šãããEPS 0.184ã«ç¶ããACADã®FY2026Q3ã®EPSã¯0.194ã«éããèŠéãã§ããçºè¡šãããå®çžŸå€ãšäºæ³ãæ¯èŒããŠãåçæ§ã®æšç§»ã確èªããŸãããã
åžå Žäºæ³ã¯ USD 0.18 ã§ããããACADIA Pharmaceuticals IncACAD ã®åååæã®äžæ ªåœããå©ç (EPS) 㯠USD 0.02 ã§ãããæ¬¡ã®ååæã® EPS 㯠USD 0.19 ãšäºæ³ãããŸãã